Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VIPR1 | P32241 | 4/20 | 0.54 |
| ▸ | VIPR2 | P41587 | 6/20 | 0.50 |
| ▸ | BACE1 | P56817 | 2/20 | 0.49 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.48 |
| ▸ | TFPI | P10646 | 1/20 | 0.47 |
| ▸ | ECE1 | P42892 | 1/20 | 0.47 |
| ▸ | GLP1R | P43220 | 1/20 | 0.47 |
| ▸ | MUS81 | Q96NY9 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29833271 | 0.95 | VIPR1 (0.52) | VIPR1VIPR2BACE1RXFP1TFPI | |
| SCHEMBL31257025 | 0.95 | BACE1 (0.49) | VIPR1VIPR2BACE1 | |
| SCHEMBL30483990 | 0.94 | VIPR1 (0.55) | VIPR1VIPR2BACE1RXFP1TFPI | |
| SCHEMBL30662325 | 0.94 | VIPR1 (0.58) | VIPR1VIPR2BACE1RXFP1TFPI | |
| SCHEMBL30712884 | 0.92 | VIPR1 (0.57) | VIPR1VIPR2BACE1RXFP1TFPI | |
| SCHEMBL30122659 | 0.92 | VIPR1 (0.53) | VIPR1VIPR2BACE1RXFP1TFPI | |
| SCHEMBL29405680 | 0.90 | VIPR1 (0.52) | VIPR1VIPR2BACE1RXFP1TFPI | |
| SCHEMBL30183026 | 0.90 | VIPR2 (0.55) | VIPR1VIPR2BACE1 | |
| SCHEMBL29453843 | 0.90 | BACE1 (0.52) | VIPR1VIPR2BACE1RXFP1GLP1R | |
| SCHEMBL29972934 | 0.90 | VIPR1 (0.48) | VIPR1VIPR2BACE1RXFP1TFPI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12213997-B1 | Compositions and methods for supporting nucleus pulposus (NP) cell phenotype and biosynthesis | WASHINGTON UNIVERSITY (US) | 2025-02-04 | — | — | US | disclosed |